152 related articles for article (PubMed ID: 33507690)
1. Cardiac, Hepatic and Renal Dysfunction and IL-18 Polymorphism in Breast, Colorectal, and Prostate Cancer Patients.
Qader G; Aali M; Smail SW; Mahmood K; Hasan B; M-Amen K; Rahman DB; Qadir FA; Mohammad DK; Najmuldeen HH; Rahman FM; Ahmad SI; Salih NS; Khdhr ZM; Mohammed BA; Majeed AM; Hasan XM; Khidhir BH; Muhammad ES; Muhamadsalih BA; Hasan SK; Hamad AJ; Esmail ZK; Ismael CM; Husaen SM; Abdulla CA; Hussen BM; Housein Z; Shekha M; Salihi A
Asian Pac J Cancer Prev; 2021 Jan; 22(1):131-137. PubMed ID: 33507690
[TBL] [Abstract][Full Text] [Related]
2. Association of rs1946518 C/A Polymorphism in Promoter Region of Interleukin 18 Gene and Breast Cancer Risk in Iranian Women: A Case-control Study.
Fathi Maroufi N; Aghayi E; Garshasbi H; Gholampour Matin M; Babazadeh Bedoustani A; Firouzi Amoudizaj F; Hajazimian S; Isazadeh A; Taefehshokr S; Taefehshokr N; Baradaran B
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):671-678. PubMed ID: 32245311
[TBL] [Abstract][Full Text] [Related]
3. Association of -607 C/A polymorphism of IL-18 gene (rs1946518) with breast cancer risk in Zahedan, Southeast Iran.
Taheri M; Hashemi M; Eskandari-Nasab E; Fazaeli A; Arababi F; Bahrani-Zeidabadi M; Bahari G
Prague Med Rep; 2012; 113(3):217-22. PubMed ID: 22980562
[TBL] [Abstract][Full Text] [Related]
4. Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population.
Patricia Gallegos-Arreola M; Zúñiga González GM; Figuera LE; Puebla Pérez AM; Delgado Saucedo JI
J BUON; 2019; 24(6):2369-2376. PubMed ID: 31983108
[TBL] [Abstract][Full Text] [Related]
5. [Association of the IL-18 gene polymorphism with susceptibility to colorectal cancer].
Guo JY; Qin AQ; Li RK; Yang CM; Huang FD; Huang ZY; Guo HJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):400-3. PubMed ID: 22539392
[TBL] [Abstract][Full Text] [Related]
6. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
8. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
11. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
[TBL] [Abstract][Full Text] [Related]
12. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women.
Pooja S; Chaudhary P; Nayak LV; Rajender S; Saini KS; Deol D; Kumar S; Bid HK; Konwar R
Cytokine; 2012 Oct; 60(1):122-8. PubMed ID: 22818022
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers for assessment of bone metastases in patients with breast cancer.
Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ
Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361
[TBL] [Abstract][Full Text] [Related]
16. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
[TBL] [Abstract][Full Text] [Related]
18. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
20. A comparison of physical activity correlates across breast, prostate and colorectal cancer survivors in Nova Scotia, Canada.
Forbes CC; Blanchard CM; Mummery WK; Courneya KS
Support Care Cancer; 2014 Apr; 22(4):891-903. PubMed ID: 24240648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]